Page 22 - Ayurvedic Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW DELHI: The Ayush ministry on Friday said it has launched a massive nationwide campaign to distribute its proven poly herbal ayurvedic drug AYUSH 64 and Sidha medicine Kabasura Kudineer for the benefit of Covid patients in home isolation. The efficacy of these drugs has been proved through robust multi-centre clinical trials, the ministry said in its statement. AYUSH-64 is recommended in National Clinical Management Protocol based on ayurveda and yoga which is vetted by National Task Force on Covid Management of ICMR and Guidelines for Ayurveda Practitioners for Covid-19 patients in home...

All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases AYUSH-64 can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said. Share Updated: May 3, 2021, 08:08 PM IST AYUSH-64, a drug developed for curing malaria in 1980, can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said on Thursday. Central Council for Research in Ayurvedic Sciences (CCRAS) recently concluded clinical trials of the drug focusing on the management of asymptomatic, ...

Antiviral drug 'Clevira' repurposed for treatment of mild to moderate COVID-19 cases Photo: Pexels Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories Private Limited said on Friday. The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. The drug has also proved to be safe on liver and kidney parameters, it said. "Clevira, an antiviral formulation, has received regulatory approval as a supportive treatment for mild to moderate C...

India News: NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate Covid-19 cases, its m.

New Delhi: Clevira, a drug primarily developed to treat dengue, has been repurposed as a supportive treatment for mild to moderate COVID-19 cases, its